爱美客：子公司诺博特取得米诺地尔搽剂药品注册证书

Core Viewpoint - Aimer's subsidiary, Beijing Nobot Biotechnology Co., Ltd., has received approval from the National Medical Products Administration for Minoxidil topical solution, which is a non-prescription dermatological medication [1] Group 1: Product Approval - The approved Minoxidil topical solution comes in two concentrations: 2% and 5% [1] - The 2% formulation is indicated for the treatment of male pattern hair loss and alopecia areata [1] - The 5% formulation is restricted for use by males only, also for treating male pattern hair loss and alopecia areata [1] Group 2: Product Functionality - Minoxidil is a peripheral vasodilator that, when used topically over a long period, can stimulate hair growth in patients with male pattern hair loss and alopecia areata [1]